Related references
Note: Only part of the references are listed.Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control
Pau Herrero et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic
E. G. Wilmot et al.
DIABETIC MEDICINE (2021)
Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
Monica Andrade Lima Gabbay et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Limits of Correlation Coefficient Analysis in Determining the Minimal Duration of CGM Data Needed to Estimate Time Below Range
Nunzio Camerlingo et al.
DIABETES (2020)
An analytical approach to determine the optimal duration of continuous glucose monitoring data required to reliably estimate time in hypoglycemia
Nunzio Camerlingo et al.
SCIENTIFIC REPORTS (2020)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Roy W. Beck et al.
DIABETES CARE (2019)
Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial
Wen Wan et al.
DIABETES CARE (2018)
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
Tonya D. Riddlesworth et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
Monika Reddy et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Martin Tauschmann et al.
LANCET (2018)
Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review
David B. Fogel
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
Thomas Haak et al.
DIABETES THERAPY (2017)
Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
Thomas Haak et al.
DIABETES THERAPY (2017)
Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange
Gina Agiostratidou et al.
DIABETES CARE (2017)
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne et al.
DIABETES CARE (2017)
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
Grazia Aleppo et al.
DIABETES CARE (2017)
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
Jan Bolinder et al.
LANCET (2016)
Methodological issues associated with clinical trials in neuropathic pain
Ian Gilron
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
The challenges of long-term follow-up data collection in non-commercial, academically-led breast cancer clinical trials: the UK perspective
Lucy S. Kilburn et al.
TRIALS (2014)
Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring
Dongyuan Xing et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Measuring the Incidence, Causes, and Repercussions of Protocol Amendments
Kenneth A. Getz et al.
DRUG INFORMATION JOURNAL (2011)
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Elbert S. Huang et al.
DIABETES CARE (2010)
An introduction to power and sample size estimation
SR Jones et al.
EMERGENCY MEDICINE JOURNAL (2003)
Share Paper
